Lopez-Mendoza D, Aguilar-Bravo H, Swanson H H
Department of Experimental Psychology, University of Seville, Spain.
Pharmacol Biochem Behav. 1998 Sep;61(1):1-8. doi: 10.1016/s0091-3057(97)00563-7.
The purpose of this investigation was to elucidate the involvement of the serotonergic 5-HT1A system in the control of aggression. The paradigm was the response of a resident mouse to an intruder into its territory. Three experiments were performed to assess the action of various doses of Gepirone (a partial agonist) and (+)WAY 100135 (a putative antagonist), separately and in combination, on aggression and on rectal body temperature. The most consistent action of Gepirone was an increase in the latency to attack. After initiation of fighting, rates of attack, chase, and tail rattling were reduced in a dose-dependent manner by i.p. administration of 2.5, 5, and 10 mg/kg of Gepirone. There was no evidence of sedation or motor impairment, but autogrooming was decreased. When doses of 2.5, 5, and 10 mg/kg of (+)WAY 100135 (WAY) were given, no effects whatsoever on aggressive or other behaviors were observed. In a third experiment, a two-factor design was followed in which injection of WAY (0, 2.5, and 5 mg/kg) was followed 15 min later by injection of Gepirone (0, 2.5, 5, and 10 mg/kg). WAY decreased attack latency, increased attack rate, and attenuated the marked dose-dependent aggression reducing properties of Gepirone. The test procedure resulted in "stress hyperthermia," which was reduced by Gepirone and increased by WAY. In both behavioral and temperature measures, the larger dose of WAY proved to be less effective than the smaller one. The results support the involvement of the 5-HT1A system in the modulation of some forms of aggression.
本研究的目的是阐明血清素能5-HT1A系统在攻击行为控制中的作用。实验范式是将一只常驻小鼠对进入其领地的入侵者的反应作为研究对象。进行了三项实验,分别评估不同剂量的吉哌隆(一种部分激动剂)和(+)WAY 100135(一种假定的拮抗剂)单独及联合使用时对攻击行为和直肠体温的影响。吉哌隆最一致的作用是攻击潜伏期延长。在开始打斗后,腹腔注射2.5、5和10mg/kg的吉哌隆可使攻击、追逐和摆尾速率以剂量依赖的方式降低。没有证据表明存在镇静或运动功能受损,但自体梳理行为减少。当给予2.5、5和10mg/kg的(+)WAY 100135(WAY)时,未观察到对攻击行为或其他行为有任何影响。在第三个实验中,采用双因素设计,先注射WAY(0、2.5和5mg/kg),15分钟后再注射吉哌隆(0、2.5、5和10mg/kg)。WAY缩短了攻击潜伏期,提高了攻击速率,并减弱了吉哌隆显著的剂量依赖性攻击行为减少特性。测试过程导致了“应激性体温过高”,吉哌隆可使其降低,而WAY可使其升高。在行为和体温测量方面,较大剂量的WAY被证明比较小剂量的效果更差。这些结果支持5-HT1A系统参与调节某些形式的攻击行为。